Strong impact of extramedullary involvement in high-risk AML patients with active disease receiving the FLAMSA conditioning regimen for HSCT

Bone Marrow Transplant. 2016 Jul;51(7):994-6. doi: 10.1038/bmt.2016.4. Epub 2016 Mar 7.

Authors

S Bohl¹, S von Harsdorf¹, M Mulaw¹, S Hofmann¹, A Babiak¹, C P Maier¹, J Schnell¹, L-M Hütter-Krönke¹, K Scholl¹, V Wais¹, R F Schlenk¹, L Bullinger¹, M Ringhoffer¹, H Döhner¹, D Bunjes¹, M Bommer¹, F Kuchenbauer¹

Affiliation

¹ Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Aged
Disease-Free Survival
Female
Hematopoietic Stem Cell Transplantation / methods*
Humans
Leukemia, Myeloid, Acute / therapy*
Male
Middle Aged
Multivariate Analysis
Neoplasm Recurrence, Local
Risk
Time Factors
Transplantation Conditioning / methods*
Treatment Outcome